139 related articles for article (PubMed ID: 2462532)
1. Immunohistochemical demonstration of pancreatic secretory trypsin inhibitor in gynecologic tumors.
Ueda G; Shimizu C; Tanaka Y; Inoue M; Tanizawa O; Ogawa M; Mori T
Gynecol Oncol; 1989 Jan; 32(1):37-40. PubMed ID: 2462532
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study on pancreatic secretory trypsin inhibitor (PSTI) in gastric carcinomas.
Higashiyama M; Monden T; Ogawa M; Matsuura N; Murotani M; Kawasaki Y; Tomita N; Murata A; Shimano T; Mori T
Am J Clin Pathol; 1990 Jan; 93(1):8-13. PubMed ID: 2403744
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic secretory trypsin inhibitor immunoreactivity detected in serum-free culture medium of human pancreatic carcinoma cell line, CAPAN-1.
Ogata N; Murata A
Res Commun Chem Pathol Pharmacol; 1988 Feb; 59(2):233-44. PubMed ID: 3358013
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of pancreatic secretory trypsin inhibitor in fetal and adult pancreatic and extrapancreatic tissues.
Fukayama M; Hayashi Y; Koike M; Ogawa M; Kosaki G
J Histochem Cytochem; 1986 Feb; 34(2):227-35. PubMed ID: 3511141
[TBL] [Abstract][Full Text] [Related]
5. [The diagnostic significance of pancreatic secretory trypsin inhibitor (PSTI) in patients with gynecologic tumors].
Inoue M; Inoue Y; Ueda G; Matsuda K; Ogawa M; Mori T
Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2225-9. PubMed ID: 6533205
[No Abstract] [Full Text] [Related]
6. Immunohistochemical analysis of pancreatic secretory trypsin inhibitor expression in pulmonary adenocarcinoma: its possible participation in scar formation of the tumor tissues.
Higashiyama M; Doi O; Kodama K; Yokouchi H; Tateishi R; Matsuura N; Murata A; Tomita N; Monden T; Ogawa M
Tumour Biol; 1992; 13(5-6):299-307. PubMed ID: 1290027
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of pancreatic secretory trypsin inhibitor in malignant pancreatic endocrine tumors.
Kamisawa T; Tu Y; Egawa N; Ishiwata J; Tsuruta K; Okamoto A; Hayashi Y; Koike M
Cancer Detect Prev; 2000; 24(6):572-8. PubMed ID: 11198271
[TBL] [Abstract][Full Text] [Related]
8. An immunohistochemical study of neuroendocrine cells in gynecologic tumors.
Ueda G; Shimizu C; Saito J; Inoue Y; Tanaka Y; Inoue M; Tanizawa O
Int J Gynaecol Obstet; 1989 Jun; 29(2):165-72. PubMed ID: 2568293
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of pancreatic secretory trypsin inhibitor in serum-free culture medium conditioned by the human pancreatic carcinoma cell line CAPAN-1.
Ogata N
J Biol Chem; 1988 Sep; 263(26):13427-31. PubMed ID: 3417664
[TBL] [Abstract][Full Text] [Related]
10. A sensitive two-site enzyme immunoassay for human pancreatic secretory trypsin inhibitor (PSTI) using monoclonal antibodies.
Kurobe M; Kono M; Yoshida N; Hayashi K
Clin Chim Acta; 1988 Dec; 178(2):205-14. PubMed ID: 3072118
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical demonstration of peptide hormones in endometrial carcinomas.
Inoue M; Ueda G; Yamasaki M; Tanaka Y; Hiramatsu K
Cancer; 1984 Nov; 54(10):2127-31. PubMed ID: 6149014
[TBL] [Abstract][Full Text] [Related]
12. MSN-1 antibody in the evaluation of female genital tract adenocarcinomas.
Poropatich C; Nozawa S; Rojas M; Chapman WB; Silverberg SG
Int J Gynecol Pathol; 1990; 9(1):73-9. PubMed ID: 2294065
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical demonstration of HNK-1-defined antigen in gynecologic tumors with argyrophilia.
Ueda G; Yamasaki M; Inoue M; Tanaka Y; Inoue Y; Abe Y; Tanizawa O
Int J Gynecol Pathol; 1986; 5(2):143-50. PubMed ID: 2424852
[TBL] [Abstract][Full Text] [Related]
14. The relation between mixed mesodermal tumors and adenocarcinomas of the ovary. An immunopathologic study.
Noorduyn LA; Herman CJ
Eur J Cancer Clin Oncol; 1987 Feb; 23(2):157-62. PubMed ID: 2832174
[TBL] [Abstract][Full Text] [Related]
15. Distribution of pancreatic secretory trypsin inhibitor in various human tissues and its inactivation in the gastric mucosa.
Shibata T; Ogawa M; Takata N; Matsuda K; Niinobu T; Uda K; Wakasugi C; Mori T
Res Commun Chem Pathol Pharmacol; 1987 Feb; 55(2):243-8. PubMed ID: 3823611
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical distribution of trypsinogen and pancreatic secretory trypsin inhibitor in normal and neoplastic tissues in man.
Marks WH; Ohlsson K; Polling A
Scand J Gastroenterol; 1984 Jul; 19(5):673-6. PubMed ID: 6382569
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical demonstration of pancreatic secretory trypsin inhibitor in normal and neoplastic colonic mucosa.
Bohe H; Bohe M; Lindström C; Ohlsson K
J Clin Pathol; 1990 Nov; 43(11):901-4. PubMed ID: 2262559
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical demonstration of neuron-specific enolase in gynecologic malignant tumors.
Inoue M; Ueda G; Nakajima T
Cancer; 1985 Apr; 55(8):1686-90. PubMed ID: 2983859
[TBL] [Abstract][Full Text] [Related]
19. The measurement of serum immunoreactive pancreatic secretory trypsin inhibitor in gastrointestinal cancer and pancreatic disease.
Satake K; Inui A; Sogabe T; Yoshii Y; Nakata B; Tanaka H; Chung YS; Hiura A; Umeyama K
Int J Pancreatol; 1988 Jul; 3(5):323-31. PubMed ID: 2459273
[TBL] [Abstract][Full Text] [Related]
20. Expression of pancreatic secretory trypsin inhibitor (PSTI) in colorectal cancer.
Higashiyama M; Monden T; Tomita N; Murotani M; Kawasaki Y; Morimoto H; Murata A; Shimano T; Ogawa M; Mori T
Br J Cancer; 1990 Dec; 62(6):954-8. PubMed ID: 2257226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
